The global intravenous (IV) iron drugs market is anticipated to grow at a significant CAGR during the forecast period. The major factor that is expected to boost the market includes the growing prevalence of chronic kidney disease (CKD), inflammatory bowel disease (IBD), and cancer around the globe, which has led to an increase in the need for intravenous iron drugs for the treatment of...